VALLEY COTTAGE, N.Y.,
April 17, 2017 /PRNewswire/ -- The
Center for the Biology of Chronic Disease (CBCD) is happy to
announce that the YouTube video
"Natural treatment vs. Acyclovir (Zovirax) and other antiviral
drugs" has gained more than half a million views. The video
is available at https://youtu.be/kJzAYDEEJt0. In the video,
Dr. Hanan Polansky and Dr.
Edan Itzkovitz describe a clinical
study that compared the natural antiviral treatment
Gene-Eden-VIR/Novirin to the three antiviral drugs Acyclovir,
Valacyclovir, and Famciclovir. The study showed that the
natural treatment is more effective and safer than the drugs.
The results of the study were published in two important
peer-reviewed medical journals, Drug Design, Development and
Therapy (1), and Clinical and Translational Medicine
(2).
The study included 139 participants. The treatment was one
to four capsules of Gene-Eden VIR/Novirin per day over a period of
2-48 months. The study included three controls recommended by
the US Food and drug Administration (FDA). The study showed
that Gene-Eden-VIR/Novirin safely and effectively decreased the
frequency and duration of genital herpes outbreaks. The
treatment was highly successful, 90.8% of the participants reported
a decrease in the number of outbreaks, and 87% reported a decrease
in the duration of their outbreaks.
The study published in Drug Design, Development and
Therapy compared the effects of the natural antiviral treatment
on the frequency of genital herpes outbreaks with the effects of
the three drugs. It is important to note that these drugs are
widely used by doctors as the first-line treatment in genital
herpes. Remarkably, the results showed that
Gene-Eden-VIR/Novirin is more effective.
The study published in Clinical and Translational
Medicine recommends "suppressive (or long term) treatment with
Gene-Eden-VIR/Novirin as a natural alternative to both suppressive
(long term) and episodic (short term) treatments with current
drugs, in both severe and mild genital herpes cases." Unlike
acyclovir, valacyclovir, and famciclovir, that have known adverse
effects, long time users of Gene-Eden-VIR/Novirin reported no
adverse effects.
Both papers are indexed on Pubmed.com. See
http://www.ncbi.nlm.nih.gov/pubmed/27621592 and
https://www.ncbi.nlm.nih.gov/pubmed/27766602. Pubmed is a
free search engine that lists abstracts in biomedicine and life
sciences. Pubmed is maintained by the United States National
Library of Medicine (NLM), at the National Institutes of Health
(NIH).
According to Dr. Hanan Polansky,
the lead author of both studies, "When it comes to my health, I
believe in science. I am happy that the public does too."
Gene-Eden-VIR/Novirin consists of five natural ingredients,
quercetin, a green tea extract, a cinnamon extract, a licorice
extract, and selenium. The Gene-Eden-VIR/Novirin formula is
patent protected. The formula was developed to target latent
(hidden) viruses. Gene-Eden-VIR/Novirin was introduced in the
marketplace at the end of 2009, and Novirin in 2014.
Media contact:
Mike Davis
The Center for the Biology of Chronic Disease (CBCD)
155086@email4pr.com
585-250-9999
(1) Hanan Polansky,
Adrian Javaherian, and Edan Itzkovitz. Clinical study in genital
herpes: natural Gene-Eden-VIR/Novirin versus acyclovir,
valacyclovir, and Famciclovir. Drug Des Devel Ther. 2016; 10:
2713–2722.
(2) Hanan Polansky,
Edan Itzkovitz, and Adrian Javaherian. Clinical study of
Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment
safely decreases the duration of outbreaks in both severe and mild
cases. Clin Transl Med. 2016 Dec;5(1):40. Epub 2016 Oct 20.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/gene-eden-virnovirin-vs-antiviral-drugs-cbcd-reports-high-interest-in-the-comparison-between-natural-treatments-and-approved-drugs-300440150.html
SOURCE The Center for the Biology of Chronic Disease
